VIPpharma ApS: Financial statements 2019
CVR: 38744763
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
VIPpharma ApS (CVR 38744763) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,119,937 and a net result of DKK -172,533 compared with DKK 228,220 the year before. That is a decrease of 23.4% compared with the year before. Equity in the 2019 report amounted to DKK 3,135,929. The solvency ratio was 81.7%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,119,937
- Profit/Loss
- DKK -172,533
- Equity
- DKK 3,135,929
- Total Assets
- DKK 3,840,611
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 1.1 mio. | -173 t. | 3.1 mio. | 2 |
| 2018 | - | 1.5 mio. | 228 t. | 3.4 mio. | - |
| 2017 | - | 1.2 mio. | 760 | 3.2 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
VIPpharma ApS has published its annual report for 2018. Gross profit came to DKK 1,461,179, and the net result was DKK 228,220.
About VIPpharma ApS
VIPpharma ApS is a Danish company of the type Anpartsselskab based in Karlslunde, founded in 2017. The company is registered under the industry Public relations og kommunikation. The management consists of Vibeke Wærens. The company is owned by VIPinvest ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 2,432,365 and a net result of DKK 674,851 compared with DKK 1,191,483 the year before. Equity in the 2025 report amounted to DKK 1,263,395.